Product Information

TIMOLOL MALEATE 0.5% EYE DROP is a generic product labeled by Bausch & Lomb Americas Inc., priced at $1.2400 per EA under NDC 82260049605. Its NADAC has been published 168 times since Aug 30, 2023.

FDA first approved this application on Nov 5, 1986. Its Orange Book therapeutic-equivalence code is AT3.

The High Outlier badge above means this manufacturer's average price in the Timolol Maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TIMOLOL MALEATE 0.5% EYE DROP

Timolol Maleate
$1.2400per EA
High Outlier

Strength

6.8 mg/mL

NDC

82260049605

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

TIMOLOL MALEATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA019463

FDA Approved

11/5/1986

TE Code

AT3

On Market Since

2/17/2022

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for TIMOLOL MALEATE 0.5% EYE DROP has been published 168 times since Aug 30, 2023, and over the history we have for it it has declined 51.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.2400 per EA
All-time high$3.7766 (Jan 10, 2024)
All-time low$1.1871 (Aug 19, 2026)
52-week high$2.0469
52-week low$1.1871
Median price$2.2055
Average price$2.1579
Largest weekly change-49.1% (Jan 17, 2024)
Weeks tracked168
Tracking sinceAug 30, 2023

Price History

1W

0.0%

1M

-1.2%

3M

-0.1%

6M

-23.7%

1Y

-40.6%

3Y

-38.2%

5Y

N/A

All

-51.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TIMOLOL MALEATE 0.5% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL MALEATE 0.5% EYE DROP, manufactured by Bausch & Lomb Americas Inc., is $1.2400 per EA (NDC 82260049605), effective Nov 11, 2026.

How has the price of TIMOLOL MALEATE 0.5% EYE DROP changed over time?

Over the history we have for it, the NADAC for TIMOLOL MALEATE 0.5% EYE DROP has declined 51.6%. It has been tracked across 168 weekly CMS publications since Aug 30, 2023.

What are the highest and lowest recorded NADAC prices for TIMOLOL MALEATE 0.5% EYE DROP?

Since Aug 30, 2023, the NADAC for TIMOLOL MALEATE 0.5% EYE DROP has ranged from a low of $1.1871 (Aug 19, 2026) to a high of $3.7766 (Jan 10, 2024), with a median of $2.2055 per EA.

Are there cheaper alternatives to TIMOLOL MALEATE 0.5% EYE DROP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TIMOLOL MALEATE 0.5% EYE DROP in a comparable dosage form, but none are currently priced below it.

Who manufactures TIMOLOL MALEATE 0.5% EYE DROP?

TIMOLOL MALEATE 0.5% EYE DROP (NDC 82260049605) is labeled by Bausch & Lomb Americas Inc., and CMS classifies it as a generic product.